Charlée Nardin Selected Research

Charlée Nardin Research Topics

Disease

18	Melanoma (Melanoma, Malignant) 01/2024 - 01/2017
6	Neoplasms (Cancer) 06/2023 - 09/2017
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 06/2018
2	Skin Neoplasms (Skin Cancer) 12/2023 - 07/2023
2	Disease Progression 01/2021 - 01/2020
2	Vitiligo 01/2020 - 01/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2024
1	Fibrosarcoma 01/2024
1	Merkel Cell Carcinoma 10/2023
1	Brain Neoplasms (Brain Tumor) 11/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Chylothorax 01/2022
1	Capillary Leak Syndrome 01/2022
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Uveal melanoma 12/2020
1	Hepatocellular Carcinoma (Hepatoma) 12/2020
1	Necrosis 11/2019
1	Febrile Neutropenia 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019
1	Pancytopenia 01/2019
1	Neutropenia 01/2019
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2019
1	Cytopenia 01/2019
1	Pure Red-Cell Aplasia 01/2019
1	Spontaneous Abortion (Miscarriage) 06/2018
1	Lung Neoplasms (Lung Cancer) 09/2017
1	Kidney Neoplasms (Kidney Cancer) 09/2017
1	Brugada Syndrome 01/2017

Drug/Important Bio-Agent (IBA)

6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 01/2017
5	Immune Checkpoint InhibitorsIBA 07/2023 - 09/2017
3	dabrafenibIBA 01/2024 - 01/2021
3	trametinibIBA 01/2024 - 01/2021
3	AntibodiesIBA 08/2023 - 01/2019
3	pembrolizumabIBA 01/2022 - 01/2019
2	NivolumabIBA 08/2023 - 01/2022
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 11/2019
2	Immune Checkpoint ProteinsIBA 01/2022 - 09/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2019
2	EnzymesIBA 01/2020 - 11/2019
2	Infliximab (Remicade)FDA Link 01/2020 - 09/2019
2	ImmunosorbentsIBA 01/2020 - 11/2019
2	InterleukinsIBA 11/2019 - 06/2018
2	Interleukin-17 (Interleukin 17)IBA 11/2019 - 06/2018
1	IpilimumabIBA 08/2023
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 06/2023
1	Cell-Free Nucleic AcidsIBA 06/2023
1	Phosphotransferases (Kinase)IBA 06/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	ArginaseIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Angiopoietin-2IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	N 30IBA 01/2020
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 01/2020
1	Interleukin-2 (IL2)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Adalimumab (Humira)FDA Link 09/2019
1	Etanercept (Enbrel)FDA Link 09/2019
1	Ustekinumab (CNTO 1275)FDA Link 09/2019
1	LigandsIBA 01/2019
1	Heme (Haem)IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	secukinumabIBA 06/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2018
1	Monoclonal AntibodiesIBA 09/2017

Therapy/Procedure

8	Therapeutics 01/2024 - 01/2020
5	Immunotherapy 06/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2021
1	Molecular Targeted Therapy 01/2024
1	Radiotherapy 10/2023
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2022
1	Contraception (Birth Control) 06/2018
1	Tubal Sterilization (Tubal Ligation) 06/2018